Nashville’s Thyme Care raises $60 million Series B
The company intends to use the funds to accelerate its national network of oncology partners in new markets and expand its comprehensive cancer care support services.
Thyme Care, a Nashville-based value-based cancer care partner, raised $60 million in Series B funding, bringing the total capital it has raised to more than $80 million.
The latest round was co-led by Town Hall Ventures of New York City and Foresite Capital of San Francisco, with participation from current investors Andreessen Horowitz Bio + Health, AlleyCorp, Casdin Capital, and Nashville’s Frist Cressey Ventures.
The company intends to use the funds to accelerate its national network of oncology partners in new markets and expand its comprehensive cancer care support services.
Co-founded by Robin Shah and Bobby Green, Thyme Care partners with health plans, employers, and risk-bearing providers to assume accountability for enhanced care quality, improved health outcomes, and reduced total cost of care. Thyme Care’s approach combines a technology-enabled Care Team and integration with providers, creating a hybrid collaborative care delivery model that guides and supports the entire patient journey.
Supported by the company’s purpose-built care management platform called Thyme Box, the Care Team is able to quickly gather context on a member, help manage their comorbidities and coordinate care with their providers, and quickly triage patients to their oncology practice when worrisome symptoms arise. Additional resources and support services for transportation, housing, food, behavioral health, financial assistance, palliative care, and more are provided to members and their caregivers to help reduce the barriers to care.
Like what you've read?
Forward to a friend!